$11.60
▼ -0.3% Today
as of Jul 22, 16:46 ET
Last 30 days
Recent Press Releases & News
Bioventus (BVS) Upgraded to Buy: Here's Why
Should Value Investors Buy Bioventus (BVS) Stock?
Bioventus (BVS) Stock Looks Overvalued On Earnings Yet Backed By Broader Checks
Overview
52-week range
$5.81
$11
100% of range
Avg surprise (last 3)
+31.8%
Avg reaction (last 2)
-4.8%
50% positive
Latest IV / EM
111%
EM ±25.4% · $13 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Wed May 6, 2026 | Mar/2026 | $0.15 | $0.09 | +66.7% | +87.5% | +2.2% | earnings |
| Sat Sep 27, 2025 | Sep 2025 | $0.05 | — | — | — | — | financials |
| Wed Aug 6, 2025 | Jun/2025 | $0.21 | $0.22 | -4.5% | — | — | earnings |
| Tue May 6, 2025 | Mar/2025 | $0.08 | $0.06 | +33.3% | — | -11.8% | earnings |
| Sat Sep 28, 2024 | Sep 2024 | $-0.08 | — | — | — | — | financials |
| Sat Jun 29, 2024 | Jun 2024 | $-0.40 | — | — | — | — | financials |
| Sat Mar 30, 2024 | Mar 2024 | $-0.08 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.12 | — | — | — | — | financials |
| Sat Jul 1, 2023 | Jul 2023 | $-0.06 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Wed Aug 5, 2026 | Jun/2026 | OTHER | $0.22 | $0.21 | +4.8% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $132M | — | $139M | $148M | $124M | — | $139M | $151M |
| Cost of revenue | $41M | — | $44M | $46M | $41M | — | $45M | $48M |
| Gross profit | $91M | — | $94M | $102M | $83M | — | $94M | $104M |
| Operating income | $8M | — | $11M | $18M | $5M | — | $4M | $-31M |
| Net income | $3M | — | $3M | $7M | $-3M | — | $-5M | $-26M |
| EPS (diluted) | $0.04 | — | $0.05 | $0.11 | $-0.04 | — | $-0.08 | $-0.40 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $36M | $51M | $42M | $33M | $23M | $42M | $43M | $32M |
| Inventory | $83M | $82M | $96M | $96M | $94M | $92M | $90M | $88M |
| Total current assets | $250M | $273M | $281M | $275M | $249M | $276M | $299M | $309M |
| Total assets | $651M | $684M | $702M | $707M | $691M | $728M | $769M | $792M |
| Long-term debt | $253M | $279M | $311M | $298M | $309M | $308M | $345M | $345M |
| Total liabilities | $416M | $455M | $494M | $505M | $506M | $542M | $583M | $603M |
| Total equity | $189M | $184M | $166M | $161M | $148M | $148M | $149M | $151M |